Eva Pharma

EVA Pharma is a leading pharmaceutical company dedicated to addressing unmet medical needs through innovative healthcare solutions.

With a heritage spanning over a century, EVA Pharma has evolved into one of the fastest-growing healthcare companies in the Middle East and Africa, operating in more than 40 countries worldwide. The company employs over 5,000 professionals, including 1,000 medical sales representatives and 200 researchers, all unified by a mission to improve and save lives by providing accessible, high-value medicines and healthcare solutions tailored to local patient needs.

Key Products and Services:

• Therapeutic Areas: EVA Pharma focuses on a broad spectrum of therapeutic areas, including:
  • Oncology
  • Neuroscience
  • Respiratory
  • Cardiometabolic medicine
  • Anti-infectives
  • Ophthalmology
  • Bone health and pain management
  • Hepatology
  • Slimming and wellbeing
  • Sexual and reproductive health
• Manufacturing Capabilities: The company operates three internationally accredited manufacturing facilities, producing over 1,000,000 packs daily, and maintains a portfolio of more than 300 products with an additional 500 in the pipeline.
• Research and Development: EVA Pharma's commitment to innovation is evident through its two research centres, which support the development of cutting-edge healthcare solutions.
• Global Partnerships: The company has a history of successful collaborations, playing a crucial role in delivering life-saving treatments for health challenges such as HIV, HBV, HCV, COVID-19, and diabetes. EVA Pharma is also pioneering technology transfer and local manufacturing of diverse biological treatments to ensure sustainable accessibility in low- to middle-income countries.
  EVA PharmaEVA Pharma's unwavering dedication to patient-centred care and its strategic focus on innovation and partnerships underscore its mission to empower the fight for health and well-being as a human right.

.